Croda International (LON:CRDA) Reaches New 12-Month Low After Insider Selling

Croda International Plc (LON:CRDA)’s share price reached a new 52-week low on Tuesday after an insider sold shares in the company. The company traded as low as GBX 2,567 ($32.68) and last traded at GBX 2,613.63 ($33.27), with a volume of 800317 shares traded. The stock had previously closed at GBX 2,754 ($35.06).

Specifically, insider Tom Brophy sold 380 shares of the stock in a transaction on Monday, April 7th. The stock was sold at an average price of GBX 2,643 ($33.64), for a total value of £10,043.40 ($12,784.37).

Croda International Stock Down 5.1 %

The company has a current ratio of 2.72, a quick ratio of 2.25 and a debt-to-equity ratio of 30.90. The stock has a market capitalization of £3.65 billion, a PE ratio of 22.46, a P/E/G ratio of 1.40 and a beta of 0.74. The stock’s fifty day simple moving average is GBX 3,114.93 and its 200-day simple moving average is GBX 3,436.35.

Croda International (LON:CRDA) last released its quarterly earnings results on Tuesday, February 25th. The company reported GBX 142.60 ($1.82) earnings per share for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. As a group, sell-side analysts forecast that Croda International Plc will post 181.8307268 EPS for the current fiscal year.

Croda International Increases Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Thursday, April 10th will be paid a GBX 63 ($0.80) dividend. This represents a dividend yield of 2.03%. The ex-dividend date of this dividend is Thursday, April 10th. This is an increase from Croda International’s previous dividend of $47.00. Croda International’s payout ratio is presently 93.66%.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.